Geoffrey R Weiss

Summary

Affiliation: University of Virginia
Country: USA

Publications

  1. pmc Doege-Potter syndrome presenting with hypoinsulinemic hypoglycemia in a patient with a malignant extrapleural solitary fibrous tumor: a case report
    Robert C Schutt
    Department of Internal Medicine, University of Virginia, PO Box 800696, Charlottesville, VA, 22908, USA
    J Med Case Rep 7:11. 2013
  2. pmc Molecular insights on the peripheral and intratumoral effects of systemic high-dose rIL-2 (aldesleukin) administration for the treatment of metastatic melanoma
    Geoffrey R Weiss
    Department of Medicine Division of Hematology Oncology, University of Virginia Health System, Charlottesville, 22908, USA
    Clin Cancer Res 17:7440-50. 2011
  3. doi request reprint Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy
    Michel Kahaleh
    Digestive Health Center, University of Virginia Health System, Charlottesville, Virginia 22908 0708, USA
    Clin Gastroenterol Hepatol 6:290-7. 2008
  4. doi request reprint Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer
    Jayme B Stokes
    Department of Surgery, University of Virginia Health System, Charlottesville, VA, USA
    Ann Surg Oncol 18:619-27. 2011
  5. pmc Clinical activity and safety of combination therapy with temsirolimus and bevacizumab for advanced melanoma: a phase II trial (CTEP 7190/Mel47)
    Craig L Slingluff
    University of Virginia, Charlottesville, VA 22908, USA
    Clin Cancer Res 19:3611-20. 2013
  6. doi request reprint Surgical management of the patient with metastatic melanoma to the heart
    Joshua M Judge
    Department of Surgery, University of Virginia Health System, Charlottesville, Virginia, USA
    J Card Surg 28:124-8. 2013
  7. ncbi request reprint Phase II trial of paclitaxel, carboplatin, and topotecan with G-CSF support in previously untreated patients with extensive stage small cell lung cancer: Southwest Oncology Group 9914
    Paul J Hesketh
    Caritas St Elizabeth s Medical Center of Boston, Boston, MA 02135, USA
    J Thorac Oncol 1:991-5. 2006
  8. ncbi request reprint Phase II study of consolidation paclitaxel after concurrent chemoradiation in poor-risk stage III non-small-cell lung cancer: SWOG S9712
    Angela M Davies
    University of California, Davis, Sacramento, CA, USA
    J Clin Oncol 24:5242-6. 2006
  9. pmc A phase II clinical trial of oral bropirimine in combination with intravesical bacillus Calmette-Guérin for carcinoma in situ of the bladder: a Southwest Oncology Group Study
    Michael F Sarosdy
    South Texas Urology and Urologic Oncology, San Antonio, TX 78229, USA
    Urol Oncol 23:386-9. 2005
  10. ncbi request reprint Phase II trial of single agent carboplatin followed by dose-intense paclitaxel, followed by maintenance paclitaxel therapy in stage IV ovarian, fallopian tube, and peritoneal cancers: a Southwest Oncology Group trial
    Maurie Markman
    Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Gynecol Oncol 88:282-8. 2003

Research Grants

  1. SOUTHWEST ONCOLOGY GROUP
    Geoffrey Weiss; Fiscal Year: 2004

Collaborators

Detail Information

Publications11

  1. pmc Doege-Potter syndrome presenting with hypoinsulinemic hypoglycemia in a patient with a malignant extrapleural solitary fibrous tumor: a case report
    Robert C Schutt
    Department of Internal Medicine, University of Virginia, PO Box 800696, Charlottesville, VA, 22908, USA
    J Med Case Rep 7:11. 2013
    ..abstract:..
  2. pmc Molecular insights on the peripheral and intratumoral effects of systemic high-dose rIL-2 (aldesleukin) administration for the treatment of metastatic melanoma
    Geoffrey R Weiss
    Department of Medicine Division of Hematology Oncology, University of Virginia Health System, Charlottesville, 22908, USA
    Clin Cancer Res 17:7440-50. 2011
    ..These effects are independent of tumor response to treatment. Here, we prospectively evaluated transcriptional alterations induced by rIL-2 in peripheral blood mononuclear cells (PBMC) and within melanoma metastases...
  3. doi request reprint Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy
    Michel Kahaleh
    Digestive Health Center, University of Virginia Health System, Charlottesville, Virginia 22908 0708, USA
    Clin Gastroenterol Hepatol 6:290-7. 2008
    ..We compared survival in patients with unresectable cholangiocarcinoma undergoing endoscopic retrograde cholangiopancreatography (ERCP) with PDT and stent placement with a group undergoing ERCP with stent placement alone...
  4. doi request reprint Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer
    Jayme B Stokes
    Department of Surgery, University of Virginia Health System, Charlottesville, VA, USA
    Ann Surg Oncol 18:619-27. 2011
    ..Patients with borderline resectable pancreatic ductal adenocarcinoma (PDA) represent a high-risk group of patients due to tumor or patient-related characteristics. The optimal management of these patients has not been fully defined...
  5. pmc Clinical activity and safety of combination therapy with temsirolimus and bevacizumab for advanced melanoma: a phase II trial (CTEP 7190/Mel47)
    Craig L Slingluff
    University of Virginia, Charlottesville, VA 22908, USA
    Clin Cancer Res 19:3611-20. 2013
    ..A CTEP-sponsored phase II trial was conducted to evaluate safety and clinical activity of combination therapy with CCI-779 (temsirolimus) and bevacizumab in patients with advanced melanoma...
  6. doi request reprint Surgical management of the patient with metastatic melanoma to the heart
    Joshua M Judge
    Department of Surgery, University of Virginia Health System, Charlottesville, Virginia, USA
    J Card Surg 28:124-8. 2013
    ..We report two cases of cardiac metastasis of melanoma and review the current literature. In addition, we propose an algorithm for dealing with this difficult problem...
  7. ncbi request reprint Phase II trial of paclitaxel, carboplatin, and topotecan with G-CSF support in previously untreated patients with extensive stage small cell lung cancer: Southwest Oncology Group 9914
    Paul J Hesketh
    Caritas St Elizabeth s Medical Center of Boston, Boston, MA 02135, USA
    J Thorac Oncol 1:991-5. 2006
    ....
  8. ncbi request reprint Phase II study of consolidation paclitaxel after concurrent chemoradiation in poor-risk stage III non-small-cell lung cancer: SWOG S9712
    Angela M Davies
    University of California, Davis, Sacramento, CA, USA
    J Clin Oncol 24:5242-6. 2006
    ..This study evaluated adding consolidation paclitaxel after chemoradiotherapy for a similar patient cohort...
  9. pmc A phase II clinical trial of oral bropirimine in combination with intravesical bacillus Calmette-Guérin for carcinoma in situ of the bladder: a Southwest Oncology Group Study
    Michael F Sarosdy
    South Texas Urology and Urologic Oncology, San Antonio, TX 78229, USA
    Urol Oncol 23:386-9. 2005
    ..To estimate the probability of response when intravesical bacille Calmette-Guérin (BCG) is given in combination with oral bropirimine for bladder carcinoma in situ, and to evaluate toxicity when the 2 agents are combined...
  10. ncbi request reprint Phase II trial of single agent carboplatin followed by dose-intense paclitaxel, followed by maintenance paclitaxel therapy in stage IV ovarian, fallopian tube, and peritoneal cancers: a Southwest Oncology Group trial
    Maurie Markman
    Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Gynecol Oncol 88:282-8. 2003
    ....
  11. ncbi request reprint Phase II trial of recombinant human interleukin-4 in patients with advanced renal cell carcinoma: a southwest oncology group study
    Robert P Whitehead
    University of Texas Medical Branch, Galveston 77555 0565, USA
    J Immunother 25:352-8. 2002
    ..Despite promising growth inhibitory and immunologic effects, IL-4 in this dose and schedule is not useful for the treatment of patients with disseminated renal cell carcinoma...

Research Grants1

  1. SOUTHWEST ONCOLOGY GROUP
    Geoffrey Weiss; Fiscal Year: 2004
    ....